| Similar Articles |
|---|
 |
Chemistry World
May 29, 2015
Emma Stoye |
UK launches universal ban on legal highs New laws banning the sale and distribution of all legal highs -- or new psychoactive substances -- have been drafted by the UK government.   |
Chemistry World
April 30, 2014
Emma Stoye |
New Zealand in legal highs U-turn Politicians in New Zealand have decided to ban designer drugs from sale in the country, reversing an earlier decision to approve low risk drugs while new laws are put in place. |
Chemistry World
June 24, 2015
Patrick Walter |
Legal in theory Governments around the world are faced with the particularly tricky problem of what they should do about 'legal highs'. |
Chemistry World
June 8, 2015
Maria Burke |
Warnings that proposed UK blanket ban on 'legal highs' casts net too wide Some legal experts and scientists are warning that a proposed blanket ban on so-called 'legal highs' won't tackle the problem and may well hold back research into areas such as neuroscience. |
Chemistry World
April 24, 2014
Emma Stoye |
European parliament backs new rules on legal highs New regulations that will make it easier to ban legal highs have been backed by the European parliament. |
Chemistry World
June 4, 2013
Maria Burke |
'Legal high' production gathers pace New designer drugs are popping up in Europe at an unprecedented rate, sometimes on the illicit drug market and sometimes as 'legal' alternatives to controlled drugs, according to the latest report by the EU drugs agency. |
Chemistry World
August 25, 2015
Rebecca Trager |
Chemists wage war on designer drugs It is relatively simple to take a drug that has a known psychoactive effect and change one substituent group to make it into another drug that is not yet classified as illegal but provides the same or similar psychoactive high |
Chemistry World
June 12, 2013
Maria Burke |
'Scientific censorship' hamstringing psychoactive drug research Legal controls on psychoactive drugs have hindered neuroscience research and the discovery of new treatments for brain disorders in 'one of the most scandalous examples of scientific censorship in modern times', claim researchers. |
American Family Physician
June 1, 2004 |
Club Drugs-Myths and Risks This article provides a general overview on the topic of club drugs like Ecstasy. |
American Family Physician
March 15, 2004 |
Substance Abuse Questions and answers on substance abuse. |
Chemistry World
May 9, 2011
Sarah Houlton |
Ecstasy substitute poses major health risks Scientists at Anglia Ruskin University haves shown that one of the most common 'legal high' designer drugs, benzylpiperazine, is not only dangerous when it's taken - repeated consumption poses major health risks. |
BusinessWeek
April 18, 2005 |
Making Those Pills Safe For Kids Few medicines get tested on children. Dr. Donald Mattison is pushing to change that. |
Managed Care
July 2005 |
Cost being equal, consumers prefer older drugs Seven out of 10 consumers would prefer a drug that had been on the market for 10 years or more, compared to a newer drug, even if the copayments were equal. This could be a sign that consumers are more inclined to start using generic medications. |
American Family Physician
April 1, 2003 |
Substance Abuse--How To Recognize It Am I drinking too much?... Am I taking risks with alcohol or other mood-altering substances?... Has my drinking or drug use become a habit?... Is alcohol or drug use taking over my life?... Has drinking alcohol or using drugs become a problem for me?... etc. |
BusinessWeek
March 7, 2005
John Carey |
Side Effects Of The Drug Scares New fears give rise to a more honest look at the risks for a pill-popping nation. |
Chemistry World
July 9, 2015
Maria Burke |
UK 'legal highs' bill under fire from scientific community Calls are growing from the scientific community for home secretary Theresa May to amend the psychoactive substances bill. |
The Motley Fool
March 20, 2007
Brian Lawler |
Smart Move by Abbott? Abbott takes a drastic measure to make a point about its patents. Thailand's actions offer a good warning of what can happen when governments try to intervene too much in existing markets. |
Pharmaceutical Executive
March 1, 2007
Patrick Clinton |
From the Editor: Incurable Eventually we're going to have lifestyle drugs, powerful ones that will make amazing differences in how we live. |
AskMen.com
Dave Golokhov |
Smart Drugs Research found in Current Directions in Psychological Science indicates that there's a limit on how smart one person can get -- no matter how much you train their brain and regardless of what type of brain-boosting drugs are on the way. |
Military & Aerospace Electronics
September 2007
Courtney E. Howard |
European Union launches Registration, Evaluation, Authorization, and Restriction of Chemicals regulation The EU's recently enacted REACH law makes industry manufacturers, importers, and systems developers responsible for the identification, management, and substitution of chemical substances. |
The Motley Fool
August 27, 2009
Brian Orelli |
The List You Have to Be On Good for you if your company's products made the cut in China. This sounds like a growth opportunity for American Oriental Bioengineering and anyone else who can get a place on the list. |
BusinessWeek
October 13, 2003
John Carey |
Drug R&D: Must Americans Always Pay? It's time for other countries to share the burden. |
The Motley Fool
August 25, 2009
Brian Orelli |
How to Keep From Losing Your Shirt More side effects for weight-loss drugs -- maybe. |
The Motley Fool
June 15, 2009
Brian Orelli |
Strange Bedfellows GlaxoSmithKline is teaming up with none other than its arch-nemesis, generic-drug maker Dr. Reddy's Laboratories, licensing more than 100 of their brands to sell in emerging markets. |
Chemistry World
January 11, 2012
Hayley Birch |
Drive towards detecting drugs at the roadside The UK government is setting up an advisory panel that will assess the feasibility of roadside testing for drug driving, similar to testing for drunk driving. |
The Motley Fool
January 8, 2008
Brian Orelli |
Brits May Bludgeon Drug Companies The U.K.'s National Health Service delivers a shock to drugmakers; it is considering a 10% drop in the rate that it pays for drugs, to help it reach its goal of a 3% reduction in the nation's overall health-care bill. |
AskMen.com
June 29, 2003
Bernie Alexander |
Worldwide Marijuana Sanctions This article explores the way the justice systems of different countries, such as the Netherlands, Mexico and Thailand, deal with crimes involving marijuana |
The Motley Fool
October 18, 2010
Brian Orelli |
Pfizer Flexes Its Generic Muscles The pharma giant moves farther into generic drugs. |
Salon.com
August 4, 2000
Gary Kamiya |
Writing high In "Writing on Drugs," Sadie Plant embarks on a stimulating trip into literature's strangest, smokiest den. |
The Motley Fool
October 6, 2008
Brian Orelli |
Cardinal Atones for Its Sins The drugmaker gets its licenses to distribute controlled substances reinstated. |
The Motley Fool
January 31, 2007
Brian Lawler |
You're Only Hurting Yourself, Thailand Thailand's decision to allow generics could do more harm than good. Investors, take note. |
Chemistry World
October 29, 2007
Arthur Rogers |
Deal to Allow Poor Nations Better Access to Cheap Drugs MEPs belatedly approved EU ratification of a 2005 World Trade Organization protocol on compulsory licensing -- potentially paving the way for developing countries to order generic drugs from manufacturers abroad without infringing patent rights. |
Pharmaceutical Executive
September 1, 2006
Patrick Clinton |
From the Editor: Undecided People are buying drugs, because companies are selling drugs. Interfere with the selling process, and people won't buy as many drugs. |
Managed Care
November 2005 |
Plans Change Tactics As Costs Keep Rising For Specialty Drugs With specialty drug costs continually increasing, CuraScript expects to see a significant shift in the percentage of plans exclusively classifying specialty drugs under the medical benefit. |
The Motley Fool
September 12, 2005
M.D. Mitchell |
Big Problems for Big Pharma Creating new drugs is never easy, but the companies that excel in three key areas are the ones for investors to watch. |
Chemistry World
September 18, 2008
James Mitchell Crow |
Ranbaxy hit by US drug ban The US Food and Drug Administration (FDA) has banned the import of more than 30 drugs made by Ranbaxy, India's largest drugmaker. |
The Motley Fool
July 29, 2010
Brian Orelli |
Buy, Sell, or Hold: Biotech Generics Generic biotech drugs are coming. Hop on. |
The Motley Fool
January 26, 2009
Brian Orelli |
Have Drugs, Will Travel After buying Bristol-Myers Squibb's businesses in Egypt and Pakistan, GlaxoSmithKline is now off to Africa. |
Chemistry World
June 17, 2014
Simon Hadlington |
Synthetic receptor recognizes entire drug family A team at the University of Brescia has developed a sensor which responds to the portion of the methamphetamine molecule that is common to the entire family. |
The Motley Fool
June 29, 2011
Brian Orelli |
Doubling Up in Biotech Lilly hits multiple targets with one drug. |
Managed Care
August 2007 |
Managed Care Outlook Specialty drugs increasingly used to treat chronic conditions. |
Chemistry World
December 21, 2015
Katrina Kramer |
BioAtla and Pfizer to collaborate on antibody research BioAtla and Pfizer will share expertise to develop tumor-targeting antibodies chemically bound to cytotoxic drugs. |
The Motley Fool
February 27, 2009
Brian Orelli |
Can $634 Billion Save the U.S. Health Care System? The good news is that Obama's budget includes a $634 billion down payment on getting insurance for the 48 million uninsured. The bad news is that the president has to pay for that by cutting costs in other areas. |
BusinessWeek
May 3, 2004
John Carey |
Is Reimporting Drugs A Cheap Fix? Not Really Why reimporting drugs from Canada won't work in the long run |
The Motley Fool
January 12, 2011
Brian Orelli |
Drugmaker Math: 4 Halves Beat 2 Wholes Eli Lilly and Boehringer Ingelheim hook up. |
The Motley Fool
May 14, 2007
Mike Havrilla |
A Weaker Amgen Amgen's stock is trading lower after an FDA panel balked at two anemia drugs. |
Reason
February 2009
Ronald Bailey |
I Want a New Drug States that adopted new drugs more rapidly, had the smallest increases in disability rates. |
Chemistry World
December 2009 |
Column: In the pipeline Is the pharmaceutical industry churning out copycat versions of existing therapies? The author dispels a few myths about 'me-too' drugs |
The Motley Fool
February 29, 2008
Brian Orelli |
Merck's Complicated Partnerships Merck has decided to continue its complicated partnership with AstraZeneca for at least a few more years. |
The Motley Fool
May 6, 2008
Brian Orelli |
Free Drugs Free over-the-counter drugs are a win-win for health insurers and their members. |
